Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Dimitrovgrad

28 clinical trials in Dimitrovgrad, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dimitrovgrad at a glance
28
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

28 trials in Dimitrovgrad

Open in trial search
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Cardiac failure

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Crd-4730
  • Sponsor:Cardurion Pharmaceuticals Inc.
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Isis 678354 Sodium Salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Dimitrovgrad

What the registry says about research in the country

01 Respiratory Diseases

Groundbreaking research focusing on severe eosinophilic asthma and chronic respiratory conditions. Multiple trials are evaluating novel therapies including dexpramipexole and tanimilast for improving patient outcomes.

  • Asthma Management Studies
  • COPD Treatment Innovations
  • Long-term Safety Evaluations

Studies aim to reduce exacerbations and enhance treatment effectiveness for patients with moderate to severe conditions.

02 Metabolic Disorders

Comprehensive research into hypertriglyceridemia treatments, including multiple trials of plozasiran and olezarsen for managing elevated triglyceride levels.

  • Severe Hypertriglyceridemia Studies
  • Novel Therapeutic Approaches
  • Long-term Efficacy Trials

Investigations focus on reducing fasting serum triglyceride levels and improving patient outcomes.

03 Cardiovascular Conditions

Advanced research examining treatments for atrial fibrillation, with studies evaluating new anticoagulation approaches and prevention of cardioembolic events.

  • Stroke Prevention Studies
  • Comparative Treatment Analysis
  • Safety Monitoring Protocols

Clinical trials are focused on developing safer and more effective treatments for cardiac conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.